Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 19, Number 10—October 2013


Melioidosis in Traveler from Africa to Spain

María I. MorosiniComments to Author , Carmen Quereda, Horacio Gil, Pedro Anda, María Núñez-Murga, Rafael Cantón, and Rogelio López-Vélez
Author affiliations: Author affiliations: Ramón y Cajal University Hospital, Madrid, Spain (M.I. Morosini, C. Quereda, R. Cantón, R. López-Vélez); and National Center for Microbiology, Madrid (H. Gil, P. Anda)

Main Article


Characteristics of reported cases of human melioidosis with African origin*

Patient age, y/sex Area visited/ diagnosed Sample type Final treatment Outcome Clinical risk factors Possible source Method of identification† Reference
64/M Kenya/Denmark Blood, urine, sputum TET+SXT Recovered Pulmonary tuberculosis NR Serology (3)
12/F Sierre Leone/The Gambia/ Bony abscesses CMP+TET No follow-up NR NR Serology (4)
40/F Mauritius Blood CTX+MDZ Died SLE Rainy season API 20NE (5)
58/M Madagascar/La Réunion (France) Sputum IMI Recovered NR Unknown API 20NE, serology, PCR (6)
29/M The Gambia, Guinea Bissau, Senegal]/Spain Soft tissue abscesses CAZ+SXT Recovered Hepatitis
Diabetes Rainy season Vitek II System, API 20NE, PCR (7)
46/F Nigeria/United Kingdom Blood MER No follow-up Diabetes Trip to Nigeria Chromatography, PCR (8)
60/M NR/France Blood IMI+CIP Recovered NR Unknown NR (9)
35/F Madagascar, West Africa/Spain Blood CAZ+DOX Recovered None Goat raw milk ingestion WIDER System,
API 20NE, serology, PCR, MLST This study

*TET, tetracycline; SXT, cotrimoxazole; NR, not reported; CMP, chloramphenicol; CTX, cefotaxime; MDZ, metronidazole; SLE, systemic lupus erythematosus; IMI, imipenem; CAZ, ceftazidime; MER, meropenem; CIP, ciprofloxacin; DOX, doxycycline; MLST, multilocus sequence typing.
†API 20NE, bioMérieux, Marcy l’Étoile, France; Vitek II System, bioMérieux; WIDER system (Fco. Soria-Melguizo, Madrid, Spain).

Main Article